Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.10 per share
-
Shares outstanding
-
1,147,663,152
-
Total 13F shares
-
640,277,265
-
Share change
-
-20,324,716
-
Total reported value
-
$5,906,782,225
-
Put/Call ratio
-
192%
-
Price per share
-
$9.23
-
Number of holders
-
434
-
Value change
-
-$439,059,091
-
Number of buys
-
196
-
Number of sells
-
234
Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) as of Q2 2019
As of 30 Jun 2019,
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) was held by
434 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
640,277,265 shares.
The largest 10 holders included
Capital Research Global Investors, WELLINGTON MANAGEMENT GROUP LLP, FRANKLIN RESOURCES INC, Berkshire Hathaway Inc, Capital World Investors, BlackRock Inc., ABRAMS CAPITAL MANAGEMENT, L.P., STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
434
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.